# FOTIVDA

NDC: 45629-134
Generic name: Tivozanib
Labeler / Manufacturer: AVEO Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20210310

FDA application: NDA212904

## Active ingredients

- TIVOZANIB HYDROCHLORIDE: 1.34 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"45629-134"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=45629-134
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=de77155c-ecf2-4f15-9758-21d271449d83